{"url_path":"/sec/sbfmw/8-k/2026-05-19/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Information.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-19","source_url":"https://www.sec.gov/Archives/edgar/data/1402328/0001683168-26-004116-index.html","accession_number":"0001683168-26-004116","cik":"0001402328","ticker":"SBFM","issuer_name":"Sunshine Biopharma Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1402328/0001683168-26-004116-index.html","primary_entity_key":"0001402328","primary_entity_name":"Sunshine Biopharma Inc."},"word_count":64,"has_tables":true,"body_markdown":"**Item 8.01. Other Information.**\n\n \n\nOn May 18, 2026, the Company\nissued a press release announcing the pricing of the Offering. A copy of the press release is filed as an exhibit to this report.\n\n \n\nOn May 19, 2026, the Company\nissued a press release announcing the closing of the Offering. A copy of the press release is filed as an exhibit to this report."}